Stock Market & Financial Investment News

News Breaks February 4, 2013 07:33 EDT RMTI Rockwell Medical announces iron delivery SFP meets primary endpoint Rockwell Medical announced successful topline results from the PRIME clinical study of Soluble Ferric Pyrophosphate, its investigational iron-delivery drug currently in Phase 3 clinical studies for the treatment of iron deficiency in hemodialysis patients. The PRIME study demonstrated that regular administration of SFP-iron via dialysate reduced the usage of erythropoietin stimulating agents (ESAs) during hemodialysis by 37.1% while maintaining iron balance and maximizing iron delivery. News For RMTI From The Last 14 Days Check below for free stories on RMTI the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 24, 2013 11:59 EDT RMTI Camber Capital reports 7.0% passive stake in Rockwell Medical May 15, 2013 09:00 EDT RMTI Rockwell Medical falls 7.5% Subscribe for More Information 07:05 EDT RMTI Rockwell Medical 11.475M share Spot Secondary priced at $3.05 Subscribe for More Information May 14, 2013 18:59 EDT RMTI On The Fly: After Hours Movers Subscribe for More Information 16:03 EDT RMTI Rockwell Medical files to sell common stock, no amount given Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.